| JYHZ2500024 | 达沙替尼片 | dasatinib | Tablet | Chemical Drugs | License Renew | 2025-02-07 | | Bristol-Myers Squibb Pharma Eeig;BRISTOL-MYERS Squibb (CHINA) Co Ltd;Patheon Inc | | | view |
| JYHZ2500026 | 达沙替尼片 | dasatinib | Tablet | Chemical Drugs | License Renew | 2025-02-07 | | Bristol-Myers Squibb Pharma Eeig;BRISTOL-MYERS Squibb (CHINA) Co Ltd;Patheon Inc | | | view |
| JYHZ2500025 | 达沙替尼片 | dasatinib | Tablet | Chemical Drugs | License Renew | 2025-02-07 | | Bristol-Myers Squibb Pharma Eeig;BRISTOL-MYERS Squibb (CHINA) Co Ltd;Patheon Inc | | | view |
| JYHZ2500023 | 达沙替尼片 | dasatinib | Tablet | Chemical Drugs | License Renew | 2025-02-07 | | Bristol-Myers Squibb Pharma Eeig;BRISTOL-MYERS Squibb (CHINA) Co Ltd;Patheon Inc | | | view |
| CYHS2403435 | 达沙替尼片 | dasatinib | Tablet | Chemical Drugs(4) | Generic Drug | 2024-10-13 | | Beijing SL Pharmaceutical Co Ltd | | | view |
| CYHS2403436 | 达沙替尼片 | dasatinib | Tablet | Chemical Drugs(4) | Generic Drug | 2024-10-13 | | Beijing SL Pharmaceutical Co Ltd | | | view |
| CYHS2403437 | 达沙替尼片 | dasatinib | Tablet | Chemical Drugs(4) | Generic Drug | 2024-10-13 | | Beijing SL Pharmaceutical Co Ltd | | | view |
| JYHB2400523 | 达沙替尼片 | dasatinib | Tablet | Chemical Drugs | Supplementary Application | 2024-10-09 | | Bristol-Myers Squibb Pharma Eeig;Patheon Inc | | | view |
| JYHB2400524 | 达沙替尼片 | dasatinib | Tablet | Chemical Drugs | Supplementary Application | 2024-10-09 | | Bristol-Myers Squibb Pharma Eeig;Patheon Inc | | | view |
| JYHB2400526 | 达沙替尼片 | dasatinib | Tablet | Chemical Drugs | Supplementary Application | 2024-10-09 | | Bristol-Myers Squibb Pharma Eeig;Patheon Inc | | | view |
| JYHB2400525 | 达沙替尼片 | dasatinib | Tablet | Chemical Drugs | Supplementary Application | 2024-10-09 | | Bristol-Myers Squibb Pharma Eeig;Patheon Inc | | | view |
| JYHB2400349 | 达沙替尼片 | dasatinib | Tablet | Chemical Drugs | Supplementary Application | 2024-07-09 | | Bristol-Myers Squibb Pharma Eeig;Patheon Inc | | | view |
| JYHB2400350 | 达沙替尼片 | dasatinib | Tablet | Chemical Drugs | Supplementary Application | 2024-07-09 | | Bristol-Myers Squibb Pharma Eeig;Patheon Inc | | | view |
| JYHB2400351 | 达沙替尼片 | dasatinib | Tablet | Chemical Drugs | Supplementary Application | 2024-07-09 | | Bristol-Myers Squibb Pharma Eeig;Patheon Inc | | | view |
| JYHB2400352 | 达沙替尼片 | dasatinib | Tablet | Chemical Drugs | Supplementary Application | 2024-07-09 | | Bristol-Myers Squibb Pharma Eeig;Patheon Inc | | | view |
| CYHB2400955 | 达沙替尼片 | dasatinib | Tablet | Chemical Drugs | Supplementary Application | 2024-07-02 | | CSPC OUYI Pharmaceutical Co Ltd | | | view |
| CYHB2400953 | 达沙替尼片 | dasatinib | Tablet | Chemical Drugs | Supplementary Application | 2024-07-02 | | CSPC OUYI Pharmaceutical Co Ltd | | | view |
| CYHB2400892 | 达沙替尼片 | dasatinib | Tablet | Chemical Drugs(原6) | Supplementary Application | 2024-06-26 | | Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd | | | view |
| CYHB2400893 | 达沙替尼片 | dasatinib | Tablet | Chemical Drugs(原6) | Supplementary Application | 2024-06-26 | | Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd | | | view |
| JTH2300271 | 达沙替尼 | dasatinib | Active ingredient | Chemical Drugs | Disposable Import Drug Application | 2023-11-25 | | Benova(Tianjin)Innovation Pharmaceutical Research Co Ltd;Granules India Ltd | | | view |
